SABS
USDSAB Biotherapeutics Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$3.140
고가
$3.330
저가
$3.140
거래량
0.08M
기업 기본 정보
시가총액
33.1M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.27M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
관련 주식
UFPI
UFP Industries Inc.
FCCO
First Community Corporation
FMS
Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)
LINC
Lincoln Educational Services Corporation
PTGX
Protagonist Therapeutics Inc.
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기